Annarita Del Gatto

Title: Annarita Del Gatto: Innovator in Peptide Antagonists

Introduction

Annarita Del Gatto is a prominent inventor based in Torre del Greco, Italy. She has made significant contributions to the field of peptide antagonists, particularly in the context of cancer treatment and diagnostic applications. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Her latest patents focus on the development of new peptide antagonists of the αβ receptor. These inventions are designed based on the crystal structure of integrin αβ in complex with c(RGDf[NMe]V) and the NMR structure of echistatin. The peptides she has developed are potent and selective antagonists of the αβ receptor. They hold promise as novel anticancer drugs and as a new class of diagnostic non-invasive tracers suitable for αβ-targeted therapy and imaging.

Career Highlights

Annarita Del Gatto is currently associated with Advanced Accelerator Applications, where she continues to innovate in her field. Her work is characterized by a strong focus on therapeutic and diagnostic applications, making her a valuable asset in the medical research community.

Collaborations

She collaborates with notable colleagues, including Laura Zaccaro and Carlo Pedone, which enhances the scope and impact of her research.

Conclusion

Annarita Del Gatto's contributions to the field of peptide antagonists are noteworthy and have the potential to significantly impact cancer treatment and diagnostics. Her innovative spirit and collaborative efforts continue to drive advancements in medical science.